🇨🇭
Switzerland · CH · 69599001
Briumvi
ReimbursedCat AATC L04AG14
Last synced from BAG Spezialitätenliste (Switzerland) on
Identification
ManufacturerNeuraxpharm Switzerland AG
CountryCH (Switzerland)
ATC codeL04AG14
DispensingA
ReimbursedYes
SourceBAG Spezialitätenliste (Switzerland)
Last synced6/4/2026
Packs · 1
- gtin7680695990010Durchstf 6 mlCHF 2338.25
Annotations
No annotations yet.
Raw payload (JSON)
{
"unit": null,
"strength": "ublituximabum 150 mg",
"valid_from": "2025-07-01",
"limitations": "[{\"description\":\"BRIUMVI wird vergütet für die Behandlung von erwachsenen Patienten mit schubförmiger Multipler Sklerose (RMS) mit aktiver Erkrankung, definiert durch klinischen Befund oder Bildgebung.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-07-01\",\"validTo\":null}]",
"galenic_form": "Inf Konz 150 mg/6ml",
"therapeutic_area": null,
"sl_inclusion_date": "2025-07-01",
"self_retention_pct": 10
}Related drugs
Other records sharing ATC code L04AG14.
Access this data programmatically
Query Briumvi and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.